{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:33:29Z","timestamp":1787924009559,"version":"build-2784847793"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["Y2023360"],"award-info":[{"award-number":["Y2023360"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03259-0","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T14:03:21Z","timestamp":1781791401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive significance of triglyceride-glucose index in forecasting adverse cardiovascular events among Type 2 diabetes mellitus patients with co-existing metabolic dysfunction-associated steatotic liver disease (MASLD): evidence from two cohort studies"],"prefix":"10.1186","volume":"25","author":[{"given":"Jing","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"3259_CR1","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Stein C, Basit A, Chan JCN, Mbanya JC, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"3259_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335\u201347.","journal-title":"Hepatology"},{"issue":"7","key":"3259_CR3","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2337\/dci24-0094","volume":"48","author":"K Cusi","year":"2025","unstructured":"Cusi K, Abdelmalek MF, Apovian CM, Balapattabi K, Bannuru RR, Barb D, Bardsley JK, Beverly EA, Corbin KD, ElSayed NA, et al. Metabolic dysfunction-associated steatotic liver disease (MASLD) in people with diabetes: the need for screening and early intervention. A consensus report of the American diabetes association. Diabetes Care. 2025;48(7):1057\u201382.","journal-title":"Diabetes Care"},{"issue":"10","key":"3259_CR4","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.cgh.2024.03.006","volume":"22","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, Golabi P, Price JK, Owrangi S, Gundu-Rao N, Satchi R, Paik JM. The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with Type 2 diabetes. Clin Gastroenterol Hepatol. 2024;22(10):1999\u20132010.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3259_CR5","doi-asserted-by":"publisher","first-page":"e076388","DOI":"10.1136\/bmj-2023-076388","volume":"384","author":"KS Kim","year":"2024","unstructured":"Kim KS, Hong S, Han K, Park CY. Association of non-alcoholic fatty liver disease with cardiovascular disease and all cause death in patients with type 2 diabetes mellitus: nationwide population based study. BMJ. 2024;384:e076388.","journal-title":"BMJ"},{"issue":"8","key":"3259_CR6","first-page":"e89355","volume":"17","author":"NK Bhatt","year":"2025","unstructured":"Bhatt NK, Agarwal Y, Neelakantan Ramaswamy S, Bendagiri Matam M, Harikrishnan S, Chand S, Bhatt H, Malasevskaia I. Evidence from a systematic review of non-alcoholic fatty liver disease (NAFLD)\/metabolic dysfunction-associated fatty liver disease (MASLD) fueling cardiovascular risk. Cureus. 2025;17(8):e89355.","journal-title":"Cureus"},{"key":"3259_CR7","doi-asserted-by":"crossref","unstructured":"Kim H, Lee DS, An TH, Park HJ, Kim WK, Bae KH, Oh KJ. Metabolic spectrum of liver failure in Type 2 diabetes and obesity: from NAFLD to NASH to HCC. Int J Mol Sci 2021;22(9):4495.","DOI":"10.3390\/ijms22094495"},{"issue":"1","key":"3259_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12933-023-01762-2","volume":"22","author":"B Che","year":"2023","unstructured":"Che B, Zhong C, Zhang R, Pu L, Zhao T, Zhang Y, Han L. Triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio as potential cardiovascular disease risk factors: an analysis of UK biobank data. Cardiovasc Diabetol. 2023;22(1):34.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3259_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12933-023-02001-4","volume":"22","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, Yang J, Tang H, Guo Z, Dong W, Wang Y, Meng X, Zhang K, Wang W, Shao C, et al. High triglyceride-glucose (TyG) index is associated with poor prognosis of heart failure with preserved ejection fraction. Cardiovasc Diabetol. 2023;22(1):263.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3259_CR10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12933-023-02054-5","volume":"22","author":"J Chen","year":"2023","unstructured":"Chen J, Wu K, Lin Y, Huang M, Xie S. Association of triglyceride glucose index with all-cause and cardiovascular mortality in the general population. Cardiovasc Diabetol. 2023;22(1):320.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3259_CR11","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1186\/s12889-024-18272-9","volume":"24","author":"J Huang","year":"2024","unstructured":"Huang J, Rozi R, Ma J, Fu B, Lu Z, Liu J, Ding Y. Association between higher triglyceride glucose index and increased risk of osteoarthritis: data from NHANES 2015\u20132020. BMC Public Health. 2024;24(1):758.","journal-title":"BMC Public Health"},{"key":"3259_CR12","doi-asserted-by":"publisher","first-page":"1322445","DOI":"10.3389\/fendo.2023.1322445","volume":"14","author":"F Zhang","year":"2023","unstructured":"Zhang F, Hou X. Association between the triglyceride glucose index and heart failure: NHANES 2007\u20132018. Front Endocrinol (Lausanne). 2023;14:1322445.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3259_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, Liu L, Ming Z, Tao X, Li Y. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc Diabetol. 2024;23(1):8.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3259_CR14","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12933-025-02783-9","volume":"24","author":"J Zhao","year":"2025","unstructured":"Zhao J, Li N, Li S, Dou J. The predictive significance of the triglyceride-glucose index in forecasting adverse cardiovascular events among type 2 diabetes mellitus patients with co-existing hyperuricemia: a retrospective cohort study. Cardiovasc Diabetol. 2025;24(1):218.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3259_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12933-023-01794-8","volume":"22","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, Fang Z, Zhang X, Wen Y, Lu J, He S, Xu B. Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study. Cardiovasc Diabetol. 2023;22(1):75.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3259_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/s12933-025-02870-x","volume":"24","author":"J Cheng","year":"2025","unstructured":"Cheng J, Cheng Q, Wu Y, Yin J, He F. Association between triglyceride-glucose-body mass index and adverse prognosis in elderly patients with severe heart failure and type 2 diabetes: a retrospective study based on the MIMIC-IV database. Cardiovasc Diabetol. 2025;24(1):299.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3259_CR17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12933-024-02343-7","volume":"23","author":"Q Chen","year":"2024","unstructured":"Chen Q, Hu P, Hou X, Sun Y, Jiao M, Peng L, Dai Z, Yin X, Liu R, Li Y, et al. Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):232.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3259_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12933-024-02263-6","volume":"23","author":"A Colantoni","year":"2024","unstructured":"Colantoni A, Bucci T, Cocomello N, Angelico F, Ettorre E, Pastori D, Lip GYH, Del Ben M, Baratta F. Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):175.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3259_CR19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12933-025-02616-9","volume":"24","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wu J, Li T, Qu Y, Wang Y. Association of triglyceride-glucose related indices with mortality among individuals with MASLD combined with prediabetes or diabetes. Cardiovasc Diabetol. 2025;24(1):52.","journal-title":"Cardiovasc Diabetol"},{"key":"3259_CR20","doi-asserted-by":"publisher","first-page":"1604398","DOI":"10.3389\/fnut.2025.1604398","volume":"12","author":"Y Yi","year":"2025","unstructured":"Yi Y, Yang L. Association between body roundness index and risks of all-cause and cardiovascular mortality in adults with metabolic dysfunction-associated steatotic liver disease: NHANES 1999\u20132018. Front Nutr. 2025;12:1604398.","journal-title":"Front Nutr"},{"issue":"1","key":"3259_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12876-025-03780-8","volume":"25","author":"T Ichikawa","year":"2025","unstructured":"Ichikawa T, Hashimoto Y, Okamura T, Obora A, Kojima T, Okada H, Hamaguchi M, Fukui M. Relationship between anthropometric measures and the risk of incident Metabolic dysfunction-associated steatotic liver disease: a longitudinal study. BMC Gastroenterol. 2025;25(1):202.","journal-title":"BMC Gastroenterol"},{"key":"3259_CR22","doi-asserted-by":"publisher","first-page":"4733","DOI":"10.2147\/DMSO.S557095","volume":"18","author":"D Sribenjalak","year":"2025","unstructured":"Sribenjalak D, Charoensri S, Kritmetapak K, Pongchaiyakul C. The association between estimated glomerular filtration rate and all-cause mortality in patients with dysglycemia in Northeastern Thailand. Diabetes Metab Syndr Obes. 2025;18:4733\u20139.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"3259_CR23","doi-asserted-by":"publisher","first-page":"e2021001","DOI":"10.4178\/epih.e2021001","volume":"43","author":"M Ould Setti","year":"2021","unstructured":"Ould Setti M, Voutilainen A, Tuomainen TP. Renal hyperfiltration, fatty liver index, and the hazards of all-cause and cardiovascular mortality in Finnish men. Epidemiol Health. 2021;43:e2021001.","journal-title":"Epidemiol Health"},{"issue":"Suppl 1","key":"3259_CR24","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc19-S002","volume":"42","author":"A American Diabetes","year":"2019","unstructured":"American Diabetes A. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S13\u201328.","journal-title":"Diabetes Care"},{"issue":"1","key":"3259_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12944-025-02708-1","volume":"24","author":"X Wang","year":"2025","unstructured":"Wang X, Qu X, Jiang G. Sex-stratified and ascorbic acid intake-modified associations between body roundness index and biological aging: a NHANES-based study on interactions and mediation. Lipids Health Dis. 2025;24(1):281.","journal-title":"Lipids Health Dis"},{"issue":"9","key":"3259_CR26","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"8","key":"3259_CR27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1542\/pir.2019-0053","volume":"41","author":"J Stewart","year":"2020","unstructured":"Stewart J, McCallin T, Martinez J, Chacko S, Yusuf S. Hyperlipidemia. Pediatr Rev. 2020;41(8):393\u2013402.","journal-title":"Pediatr Rev"},{"key":"3259_CR28","doi-asserted-by":"crossref","unstructured":"Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, Dixon DL, Fearon WF, Hess B, Johnson HM et al. 2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American heart association\/American college of cardiology joint committee on clinical practice guidelines. Circulation. 2023;148(9):e9-e119.","DOI":"10.1161\/CIR.0000000000001183"},{"issue":"1","key":"3259_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/apt.13012","volume":"41","author":"CE Ruhl","year":"2015","unstructured":"Ruhl CE, Everhart JE. Fatty liver indices in the multiethnic United States national health and nutrition examination survey. Aliment Pharmacol Ther. 2015;41(1):65\u201376.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"3259_CR30","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1159\/000539371","volume":"17","author":"European Association for the Study of the L, European Association for the Study of D","year":"2024","unstructured":"European association for the study of the L, European association for the study of D. European association for the study of O: EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Obes Facts. 2024;17(4):374\u2013444.","journal-title":"Obes Facts"},{"issue":"1","key":"3259_CR31","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.21669","volume":"46","author":"A Vallet-Pichard","year":"2007","unstructured":"Vallet-Pichard A, Mallet V, Nalpas B, Verkarre V, Nalpas A, Dhalluin-Venier V, Fontaine H, Pol S. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest. Hepatology. 2007;46(1):32\u20136.","journal-title":"Hepatology"},{"issue":"1","key":"3259_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12933-024-02555-x","volume":"24","author":"C Li","year":"2025","unstructured":"Li C, Zhao S, Li Y, He S, Jian W, Liu Y, Cheng Z, Peng H. Triglyceride-glucose index predicts adverse cardiovascular events in patients with H-type hypertension combined with coronary heart disease: a retrospective cohort study. Cardiovasc Diabetol. 2025;24(1):45.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3259_CR33","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12933-023-02030-z","volume":"22","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Xiao S, Jiao X, Shen Y. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001\u20132018. Cardiovasc Diabetol. 2023;22(1):279.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3259_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12933-023-01737-3","volume":"22","author":"R Zhang","year":"2023","unstructured":"Zhang R, Shi S, Chen W, Wang Y, Lin X, Zhao Y, Liao L, Guo Q, Zhang X, Li W, et al. Independent effects of the triglyceride-glucose index on all-cause mortality in critically ill patients with coronary heart disease: analysis of the MIMIC-III database. Cardiovasc Diabetol. 2023;22(1):10.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3259_CR35","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12933-024-02152-y","volume":"23","author":"Q Liu","year":"2024","unstructured":"Liu Q, Zhang Y, Chen S, Xiang H, Ouyang J, Liu H, Zhang J, Chai Y, Zhan Z, Gao P, et al. Association of the triglyceride-glucose index with all-cause and cardiovascular mortality in patients with cardiometabolic syndrome: a national cohort study. Cardiovasc Diabetol. 2024;23(1):80.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3259_CR36","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12933-024-02261-8","volume":"23","author":"C Liu","year":"2024","unstructured":"Liu C, Liang D. The association between the triglyceride-glucose index and the risk of cardiovascular disease in US population aged <\/= 65 years with prediabetes or diabetes: a population-based study. Cardiovasc Diabetol. 2024;23(1):168.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3259_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12933-024-02215-0","volume":"23","author":"X Wei","year":"2024","unstructured":"Wei X, Min Y, Song G, Ye X, Liu L. Association between triglyceride-glucose related indices with the all-cause and cause-specific mortality among the population with metabolic syndrome. Cardiovasc Diabetol. 2024;23(1):134.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3259_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12944-017-0409-6","volume":"16","author":"S Zhang","year":"2017","unstructured":"Zhang S, Du T, Zhang J, Lu H, Lin X, Xie J, Yang Y, Yu X. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids Health Dis. 2017;16(1):15.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3259_CR39","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12933-022-01548-y","volume":"21","author":"J Zhao","year":"2022","unstructured":"Zhao J, Fan H, Wang T, Yu B, Mao S, Wang X, Zhang W, Wang L, Zhang Y, Ren Z, et al. TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients. Cardiovasc Diabetol. 2022;21(1):123.","journal-title":"Cardiovasc Diabetol"},{"key":"3259_CR40","doi-asserted-by":"publisher","first-page":"1083032","DOI":"10.3389\/fendo.2023.1083032","volume":"14","author":"H Peng","year":"2023","unstructured":"Peng H, Pan L, Ran S, Wang M, Huang S, Zhao M, Cao Z, Yao Z, Xu L, Yang Q, et al. Prediction of MAFLD and NAFLD using different screening indexes: a cross-sectional study in U.S. adults. Front Endocrinol (Lausanne). 2023;14:1083032.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"3259_CR41","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1007\/s10620-024-08309-9","volume":"69","author":"ME Khamseh","year":"2024","unstructured":"Khamseh ME, Malek M, Jahangiri S, Nobarani S, Hekmatdoost A, Salavatizadeh M, Soltanieh S, Chehrehgosha H, Taheri H, Montazeri Z, et al. Insulin resistance\/sensitivity measures as screening indicators of metabolic-associated fatty liver disease and liver fibrosis. Dig Dis Sci. 2024;69(4):1430\u201343.","journal-title":"Dig Dis Sci"},{"key":"3259_CR42","doi-asserted-by":"crossref","unstructured":"Song S, Son DH, Baik SJ, Cho WJ, Lee YJ. Triglyceride glucose-waist circumference (TyG-WC) is a reliable marker to predict non-alcoholic fatty liver disease. Biomedicines. 2022;10(9):2251.","DOI":"10.3390\/biomedicines10092251"},{"issue":"1","key":"3259_CR43","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12933-024-02354-4","volume":"23","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang F, Tang J, Shen L, He J, Chen Y. Association of triglyceride glucose-related parameters with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999\u20132018. Cardiovasc Diabetol. 2024;23(1):262.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3259_CR44","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s12967-022-03678-z","volume":"20","author":"Y Yu","year":"2022","unstructured":"Yu Y, Gu M, Huang H, Cheng S, Deng Y, Cai C, Chen X, Niu H, Ning X, Hua W. Combined association of triglyceride-glucose index and systolic blood pressure with all-cause and cardiovascular mortality among the general population. J Transl Med. 2022;20(1):478.","journal-title":"J Transl Med"},{"issue":"1","key":"3259_CR45","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12933-024-02269-0","volume":"23","author":"C Liu","year":"2024","unstructured":"Liu C, Liang D, Xiao K, Xie L. Association between the triglyceride-glucose index and all-cause and CVD mortality in the young population with diabetes. Cardiovasc Diabetol. 2024;23(1):171.","journal-title":"Cardiovasc Diabetol"},{"key":"3259_CR46","doi-asserted-by":"publisher","first-page":"5245308","DOI":"10.1155\/2020\/5245308","volume":"2020","author":"C Khatana","year":"2020","unstructured":"Khatana C, Saini NK, Chakrabarti S, Saini V, Sharma A, Saini RV, Saini AK. Mechanistic insights into the oxidized low-density lipoprotein-induced atherosclerosis. Oxid Med Cell Longev. 2020;2020:5245308.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"3259_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11906-015-0615-4","volume":"18","author":"MN Molina","year":"2016","unstructured":"Molina MN, Ferder L, Manucha W. Emerging role of nitric oxide and heat shock proteins in insulin resistance. Curr Hypertens Rep. 2016;18(1):1.","journal-title":"Curr Hypertens Rep"},{"key":"3259_CR48","doi-asserted-by":"publisher","first-page":"110691","DOI":"10.1016\/j.diabres.2023.110691","volume":"200","author":"S Suren Garg","year":"2023","unstructured":"Suren Garg S, Kushwaha K, Dubey R, Gupta J. Association between obesity, inflammation and insulin resistance: insights into signaling pathways and therapeutic interventions. Diabetes Res Clin Pract. 2023;200:110691.","journal-title":"Diabetes Res Clin Pract"},{"key":"3259_CR49","doi-asserted-by":"crossref","unstructured":"Perticone M, Maio R, Gigliotti S, Shehaj E, Toscani AF, Capomolla A, Fabiani G, Sciacqua A, Perticone F. Mutual effect modification between insulin resistance and endothelial dysfunction in predicting incident heart failure in hypertensives. Biomedicines. 2023;11(8):2188.","DOI":"10.3390\/biomedicines11082188"},{"issue":"3","key":"3259_CR50","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11892-006-0031-x","volume":"6","author":"G Boden","year":"2006","unstructured":"Boden G. Fatty acid-induced inflammation and insulin resistance in skeletal muscle and liver. Curr Diab Rep. 2006;6(3):177\u201381.","journal-title":"Curr Diab Rep"},{"key":"3259_CR51","doi-asserted-by":"crossref","unstructured":"Janssen J. Overnutrition, hyperinsulinemia and ectopic fat: it is time for a paradigm shift in the management of type 2 diabetes. Int J Mol Sci. 2024;25(10):5488.","DOI":"10.3390\/ijms25105488"},{"key":"3259_CR52","doi-asserted-by":"crossref","unstructured":"Martinez-Rojas MA, Balcazar H, Gonzalez-Soria I, Gonzalez-Rivera JM, Rodriguez-Vergara ME, Velazquez-Villegas LA, Leon-Contreras JC, Perez-Villalva R, Correa F, Rosetti F et al. Transient inhibition of sodium-glucose cotransporter 2 after ischemia\/reperfusion injury ameliorates chronic kidney disease. JCI Insight. 2024;9(6):e173675.","DOI":"10.1172\/jci.insight.173675"},{"key":"3259_CR53","doi-asserted-by":"crossref","unstructured":"Patera F, Gatticchi L, Cellini B, Chiasserini D, Reboldi G. Kidney fibrosis and oxidative stress: from molecular pathways to new pharmacological opportunities. Biomolecules. 2024;14(1):137.","DOI":"10.3390\/biom14010137"},{"issue":"2","key":"3259_CR54","doi-asserted-by":"publisher","first-page":"102344","DOI":"10.1016\/j.cpcardiol.2023.102344","volume":"49","author":"SA Sebastian","year":"2024","unstructured":"Sebastian SA, Padda I, Johal G. Cardiovascular-Kidney-Metabolic (CKM) syndrome: a state-of-the-art review. Curr Probl Cardiol. 2024;49(2):102344.","journal-title":"Curr Probl Cardiol"},{"issue":"1","key":"3259_CR55","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12933-025-02824-3","volume":"24","author":"E Han","year":"2025","unstructured":"Han E, Han KD, Lee YH, Kim KS, Hong S, Park JH, Park CY. Fatty liverresearch group of the Korean diabetes a: association of temporal masld with type 2 diabetes, cardiovascular disease and mortality. Cardiovasc Diabetol. 2025;24(1):289.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3259_CR56","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s12933-025-02941-z","volume":"24","author":"M Gan","year":"2025","unstructured":"Gan M, Chen B, Qin M, Zhang L, Wang X. Association between atherogenic index of plasma (AIP) and all-cause and cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): a cohort study based on NHANES 1999\u20132018. Cardiovasc Diabetol. 2025;24(1):391.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03259-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03259-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03259-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:05:35Z","timestamp":1787922335000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03259-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3259"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03259-0","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the Second Affiliated Hospital of Wenzhou Medical University (2025-K-270-01, dated February 15, 2025). The author waived the requirement for patients\u2019 written informed consent for the anonymity of patients was strictly confidential and the current work was based on observation. All methods were performed in accordance with the relevant guidelines and regulations.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"262"}}